|Venture Round, 8/09 |
Whalehaven Capital Fund
Paramount BioCapital Asset Management
CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company’s core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.